PPARD and neuropathy: Given the role that the polyol pathway and aldose reductase have in the formation of toxic advanced glycation end-products and the resultant diabetic complications, such as neuropathy, nephropathy and retinopathy, a decrease in the activity of this pathway may prove a significant anti-diabetic effect of PPARδ activation [29].